Views & Analysis Data: underpinning health R&D Big data initiatives positioning the UK as a desirable location for R&D.
News Rare leukaemia drug gets funding for phase 2 trial Investment fund kick-starts phase 2 trial in CMML
News Innate and BMS' immunotherapy fails in phase 2 trial French biotech developing cancer immunotherapy with BMS.
News Kyowa Kirin to expand UK headquarters despite Brexit Other Japanese firms could scale back UK investment.
News Invest in NHS to boost life sciences, says pharma body Make NHS best place to research and launch drugs, says ABPI.
News BMS suffers further setback in lung cancer No fast approval for immunotherapy combo in first line use.
Sales & Marketing Biotech is back, with Craig Ackerman In Philadelphia this month, pharmaphorum spoke with Craig Ackerman, a partner at the Alexander Group, about launches, AI best practices, and more.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
